The Hamburg-based Nordrad Norddeutsche Radiologie Gesellschaft mbH & Co. KGaA acquired all of the shares in Diagnoseklinik München.de GmbH from the founding and sole shareholder Dr med. Bernd Dörflinger. The hospital specialises in image-guided high-tech diagnostics and therapy being one of the leading private hospitals for preventive genetic diagnostics in Europe. The transaction also included the sale of Diagnoseklinik’s subsidiary
Curameda GmbH, which specialises in the creation and operation of out-patient nursing services and the co-operation with service providers in the healthcare sector.
A Linklaters team led by Dr Rainer Traugott (corporate/M&A, Munich) provided comprehensive advice in connection with this transaction to Dr Bernd Dörflinger and Altium Capital AG (acting as financial adviser to the seller).
The team also included Dr Philipp Strümpell, Dr Franz Schaefer, Julia Schechner, Dr Martina Wind (all corporate/M&A, Munich), Andreas Schaflitzl, Dr Christoph Götz (both tax, Munich), Marianne Waldenmaier, Carolin Goll-Müller (both employment, Munich) as well as Dr Konrad Berger (data protection, Munich).
